Related Experiment Video
Updated: Jan 27, 2026

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
Bacteriotherapy in children with recurrent upper respiratory tract infections
V Tarantino1, V Savaia, R D'Agostino
1Dipartimento Testa-Collo e Neuroscienze - IRCCS Istituto Giannina Gaslini, Genoa, Italy gio.cip@libero.it.
Insights
Bacteriotherapy using a nasal spray significantly reduced recurrent upper-airway infections (UI) in children. This treatment also decreased school and work absences, offering a potential preventive strategy for frequent infections.
Area of Science:
- Pediatric infectious diseases
- Microbiome therapeutics
- Respiratory health
Background:
- Recurrent upper-airway infections (UI) in children impose significant social and economic burdens on families.
- Bacteriotherapy presents a novel approach to potentially prevent recurrent infections by modulating the microbial environment.
Purpose of the Study:
- To evaluate the efficacy of bacteriotherapy in preventing recurrent upper-airway infections (UI) in children.
- To assess the impact of bacteriotherapy on school and work absenteeism related to UI.
Main Methods:
- An open-label study involving 80 children with recurrent UI.
- Treatment administered via a nasal spray containing Streptococcus salivarius 24SMB and Streptococcus oralis 89a for one week, repeated for three months.
- Outcomes measured included the number of UI and associated school/work absences, compared to the previous year.
Main Results:
- A significant reduction in the mean number of UI from 5.98 to 2.75 post-treatment (p<0.0001).
- Significant decreases in school absences (4.50 to 2.80, p<0.0001) and work absences (2.33 to 1.48, p<0.0001) were observed.
- The results indicate a strong positive effect of the bacteriotherapy intervention.
Conclusions:
- Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray shows promise in preventing recurrent UI in pediatric populations.
- This preliminary study suggests a viable therapeutic option for managing recurrent respiratory infections in children.
- Further research is warranted to confirm these findings in larger, controlled trials.
Objective:
Children with recurrent upper-airway infections (UI) represent a social issue for their economic burden and negative impact on families. Bacteriotherapy is a new therapeutic strategy that could potentially prevent infections. The current study tested the hypothesis that recurrent UI may be prevented by bacteriotherapy.
Patients And Methods:
This open study was conducted in an outpatient clinic, enrolling 80 children (40 males, mean age 5.26±2.52 years) suffering from recurrent UI. Children were treated with a nasal spray containing Streptococcus salivarius 24SMB and Streptococcus oralis 89a, 2 puffs per nostril twice a day for a week; this course was repeated for 3 months. The evaluated parameters were: number of UI and number of school and work absences; these outcomes were compared with those recorded in the past year.
Results:
The mean number of UI significantly diminished: from 5.98 (2.30) in the past year to 2.75 (2.43) after treatment (p<0.0001). The number of school and work absences significantly diminished (from 4.50±2.81 to 2.80±3.42 and from 2.33±2.36 to 1.48±2.16 respectively; p<0.0001 for both).
Conclusions:
This preliminary experiment suggests that bacteriotherapy using Streptococcus salivarius 24SMB and Streptococcus oralis89a nasal spray could prevent recurrent UI in children.
More Related Videos
06:22Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
Published on: September 19, 2025
06:11Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
Related Concept Videos
Anatomy of Respiratory System I: Upper Respiratory Tract
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract....
Anatomy of Respiratory System II: Lower Respiratory Tract
The Larynx
It is located between the pharynx and the trachea, acts as a passageway for air, and hosts several critical structures, such as the epiglottis, vocal cords, and glottis. The epiglottis acts as a gateway, guiding food to the...
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Physical Assessment of the Respiratory Tract II: Palpation
Thoracic Palpation
Thoracic palpation detects tenderness, masses, lesions, respiratory excursions, and vocal fremitus. The nurse assesses...